+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

Hypercholesterolemia - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Hypercholesterolemia - Global Clinical Trials Review, 2024

  • Clinical Trials
  • May 2024
  • 1282 Pages
  • Global
From
Acute Ischemic Stroke (AIS) - Competitive Landscape - Product Thumbnail Image

Acute Ischemic Stroke (AIS) - Competitive Landscape

  • Report
  • December 2023
  • 77 Pages
  • Global
From
From
From
From
Intracranial Aneurysm Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Intracranial Aneurysm Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Ischemic Stroke Market Report and Forecast 2024-2032 - Product Thumbnail Image

Ischemic Stroke Market Report and Forecast 2024-2032

  • Report
  • May 2024
  • 160 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more